Moreover, both the control and PCOS oocytes showed an increase in intracellular GSH level in the 1 (227.9 ± 12.64 vs 191.3 ± 8.38, p = 0.017 and 158 ± 6.32 vs 102.83 ± 3.14, p = 0.0083) and 50 (236.9 ± 12.64 vs 191.3 ± 8.38, p = 0.0057 and 164.67 ± 15.8 vs 102.83 ± 3.14, p = 0.0023) μg/ml NSE-treated oocytes as compared to the untreated oocytes, respectively (Figure 1). The gene discussed is ENO2; the disease is polycystic ovary syndrome.